tiprankstipranks
Trending News
More News >
Alexandria Real Estate Equities (ARE)
NYSE:ARE
Advertisement

Alexandria Equities (ARE) AI Stock Analysis

Compare
1,044 Followers

Top Page

ARE

Alexandria Equities

(NYSE:ARE)

Rating:58Neutral
Price Target:
$86.00
▲(15.42% Upside)
Alexandria Equities scores 70, driven by strong financial performance and positive earnings call sentiment, despite mixed technical indicators and an unfavorable valuation. The company's robust cash flow and strategic leasing activity are significant strengths, while occupancy declines and challenges in the biotech sector pose risks.
Positive Factors
Financial Performance
Investment income came in strong, with ARE realizing ~$32.1m of investment gains during the quarter, above estimates.
Leasing Activity
ARE executed on 1.3m sq.ft. of leasing activity during the quarter, which is above historical averages, a positive given high supply in the market.
Stock Valuation
ARE is trading at an approximately 30% discount to NAV, offering a potential total return of around 39% including capital appreciation and yield.
Negative Factors
Job Market
Life science job listings in ARE's markets continued to decline, with job listings soft relative to the 'go-go' years of 2020-2022, and below the average of '18-'19.
Market Conditions
New supply continues to be an overhang, with high vacancy rates in the nation's two largest lab markets, the Bay Area and Boston.
Supply and Demand
Supply/demand imbalance remains a concern for the asset class, which limits the growth outlook through '26 due to occupancy headwinds, narrowing re-leasing spreads, and minimal accretion from development.

Alexandria Equities (ARE) vs. SPDR S&P 500 ETF (SPY)

Alexandria Equities Business Overview & Revenue Model

Company DescriptionAlexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust (REIT), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million square feet (SF). The asset base in North America includes 31.9 million RSF of operating properties and 3.3 million RSF of Class A properties undergoing construction, 7.1 million RSF of near-term and intermediate-term development and redevelopment projects, and 7.4 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, technology, and agtech campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, technology, and agtech companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
How the Company Makes MoneyAlexandria Equities generates revenue primarily through leasing its properties to tenants in the life sciences and technology sectors. The company's revenue model is based on long-term leases, which provide a stable income stream. Key revenue streams include rental income from both traditional office spaces and specialized lab facilities. Alexandria also engages in development projects, enhancing its portfolio's value and generating additional income through the eventual leasing of these newly developed spaces. Significant partnerships with universities and research institutions further contribute to its earnings by securing long-term tenants and fostering collaborative environments that attract additional clients.

Alexandria Equities Earnings Call Summary

Earnings Call Date:Jul 21, 2025
(Q2-2025)
|
% Change Since: -4.80%|
Next Earnings Date:Oct 27, 2025
Earnings Call Sentiment Neutral
The call reflects a positive sentiment with notable achievements such as the largest lease in company history and strong financial performance. However, challenges remain with occupancy declines and pressures in the biotech market, indicating a balanced view.
Q2-2025 Updates
Positive Updates
Largest Lease in Company History
Alexandria signed the largest lease in its history for 466,000 square feet at the Campus Point Megacampus in San Diego with a top 20 pharma company, illustrating the strength of their Megacampus platform.
Strong Financial Performance
FFO per share diluted as adjusted was $2.33 for Q2 2025, up 1.3% compared to the prior quarter, due to the positive impact from recent development deliveries.
Solid Leasing Activity
Leasing spreads were 5.5% on a cash basis with a relatively high average lease duration of 9.4 years. Tenant improvements and leasing commissions on renewals were down 40% compared to the previous two quarters.
G&A Cost Savings
Significant progress was made towards annual savings for 2025, with trailing 12-month G&A costs at 6.3% of NOI, the lowest level in the past 10 years.
Robust Pipeline and Asset Recycling
Alexandria has a $1.1 billion executable sales pipeline for the next 2 quarters and is focused on asset recycling to raise significant equity-light capital.
Negative Updates
Occupancy Decline
Occupancy at the end of the quarter was at 90.8%, down 90 basis points from the prior quarter, with pressure expected to continue in the second half of 2025.
Challenges in Biotech Public Equity Markets
No biotech IPOs occurred in the second quarter, and the risk-off environment is expected to continue until interest rates subside.
Same-Property NOI Decline
Same-property NOI was down 5.4% for the quarter, with continued pressure expected in the second half of 2025 due to recent occupancy declines.
Impairments of Real Estate
Recognized impairments of $129.6 million during the quarter, with a significant portion coming from a land parcel and an office property in Northern San Diego.
Company Guidance
During the Alexandria Real Estate Equities Second Quarter 2025 conference call, the company provided guidance on various financial and operational metrics, reflecting its solid performance amidst challenging macroeconomic conditions. Key highlights included the execution of the largest lease in the company's history, a 466,000 square foot lease with a high-credit tenant, which underscores Alexandria's brand trust and product quality. The company's focus on its stabilization pipeline for 2027 and beyond was emphasized, with progress reported on assets such as 311 Arsenal and 701 Dexter. Asset sales remain a focal point, with $1.1 billion added to the executable sales pipeline for the next two quarters. The company also anticipates the Federal Reserve to lower interest rates in the coming quarters, which is deemed critical for the capital markets. In terms of leasing, 80% of the second quarter's activity was driven by the diversity of their tenant base, with private biotechnology companies representing 30% of overall leasing. The company remains confident in its long-term growth, supported by the robust biopharma ecosystem, despite current uncertainties in the macroeconomic environment.

Alexandria Equities Financial Statement Overview

Summary
Alexandria Equities presents a strong financial profile with consistent revenue growth, robust profitability, and efficient cash flow generation. The balance sheet is solid, with a strong equity position and zero debt recently, although past leverage fluctuations need monitoring.
Income Statement
88
Very Positive
Alexandria Equities has shown robust revenue growth over the years, with a notable increase from 2019 to 2024. The Gross Profit Margin and Net Profit Margin have been strong, reflecting efficient operations and good cost management. The EBIT and EBITDA margins are healthy, indicating strong operational performance. Overall, the income statement reflects a well-managed growth trajectory with stable profitability.
Balance Sheet
79
Positive
The company's balance sheet is strong, with significant stockholders' equity and a zero debt level in the most recent year, indicating excellent financial health and stability. The Equity Ratio is solid, showing a healthy proportion of equity financing. However, fluctuations in the debt levels over previous years suggest attention to leverage management is necessary.
Cash Flow
82
Very Positive
Alexandria Equities has demonstrated positive free cash flow, with good growth over the years. The Operating Cash Flow to Net Income Ratio is favorable, indicating efficient cash flow generation relative to earnings. While there have been fluctuations in free cash flow, the company maintains a strong cash position, highlighting its ability to manage cash effectively.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.04B3.05B2.84B2.59B2.11B1.89B
Gross Profit2.12B2.14B1.98B1.81B1.49B1.36B
EBITDA1.84B1.90B1.45B1.63B1.35B1.23B
Net Income-12.85M322.95M103.64M521.66M416.83M591.20M
Balance Sheet
Total Assets37.62B37.53B36.77B35.52B30.22B22.83B
Cash, Cash Equivalents and Short-Term Investments520.54M552.15M618.19M825.19M361.35M568.53M
Total Debt13.66B12.75B11.70B10.16B8.79B7.56B
Total Liabilities15.88B15.13B14.15B12.84B11.19B9.38B
Stockholders Equity17.18B17.89B18.47B18.97B16.19B11.73B
Cash Flow
Free Cash Flow1.42B1.50B1.63B1.29B-6.32B-2.39B
Operating Cash Flow1.42B1.50B1.63B1.29B1.01B882.51M
Investing Cash Flow-1.03B-1.51B-2.50B-5.08B-7.11B-3.28B
Financing Cash Flow-425.32M-93.31M674.16M4.23B5.92B2.75B

Alexandria Equities Technical Analysis

Technical Analysis Sentiment
Negative
Last Price74.51
Price Trends
50DMA
75.10
Negative
100DMA
75.56
Negative
200DMA
86.86
Negative
Market Momentum
MACD
-0.68
Positive
RSI
45.55
Neutral
STOCH
40.74
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ARE, the sentiment is Negative. The current price of 74.51 is below the 20-day moving average (MA) of 77.31, below the 50-day MA of 75.10, and below the 200-day MA of 86.86, indicating a bearish trend. The MACD of -0.68 indicates Positive momentum. The RSI at 45.55 is Neutral, neither overbought nor oversold. The STOCH value of 40.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ARE.

Alexandria Equities Risk Analysis

Alexandria Equities disclosed 11 risk factors in its most recent earnings report. Alexandria Equities reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Alexandria Equities Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$6.24B21.799.67%4.32%2.95%
68
Neutral
$4.64B74.761.30%4.60%13.07%-4.94%
63
Neutral
$6.82B13.27-0.71%7.18%3.67%-27.43%
61
Neutral
$7.69B9.1114.93%1.96%1.38%4370.96%
58
Neutral
$12.75B102.63-0.12%7.06%3.12%-116.29%
58
Neutral
$4.08B663.10-0.37%5.51%15.25%79.18%
57
Neutral
$11.08B3,215.660.07%5.98%3.24%-97.73%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ARE
Alexandria Equities
74.51
-34.22
-31.47%
BXP
Boston Properties
65.21
-0.73
-1.11%
CUZ
Cousins Properties
27.80
1.71
6.55%
SLG
SL Green Realty
54.47
-6.25
-10.29%
VNO
Vornado Realty
37.05
5.76
18.41%
CDP
COPT Defense Properties
27.79
0.21
0.76%

Alexandria Equities Corporate Events

Executive/Board ChangesShareholder Meetings
Alexandria Equities Approves Key Proposals at Annual Meeting
Neutral
May 15, 2025

On May 13, 2025, Alexandria Real Estate Equities, Inc. held its 2025 Annual Meeting of Stockholders, where several key proposals were approved, including the amendment and restatement of the Amended 1997 Incentive Plan. This amendment increases the number of shares available for grant, specifies the treatment of performance-based awards in the event of a change of control, and clarifies the prohibition of granting stock options and stock appreciation rights. Additionally, the meeting saw the election of eight directors, approval of executive compensation, ratification of Ernst & Young LLP as auditors, and the approval of a stockholder proposal titled ‘Simple Majority Vote’.

The most recent analyst rating on (ARE) stock is a Hold with a $117.00 price target. To see the full list of analyst forecasts on Alexandria Equities stock, see the ARE Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 31, 2025